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Off-pump coronary artery bypass surgery (OPCAB) has experi-enced a revival since the early 1990s, with the emergence of twoschools of thought. The school in favor of OPCAB emphasizesthe potential of reducing morbidity while allowing undevelopedcountries to access a program of coronary surgery at reduced cost.The other school expresses concern because of the potential for
intraoperative myocardial ischemia, suboptimal anastomoses, and a protracted
learning curve. Progressively, a variety of innovative techniques and enabling
instruments have made OPCAB a standard procedure. Concomitantly, a large
number of observational, case-matched, and, not least, prospective randomized
studies have been published. In the absence of recognized guidelines, the decision
whether to use on-pump or off-pump techniques is often left to individual surgeons.
Many are enthusiastically jumping on the OPCAB bandwagon, whereas others are
adopting an even more conservative approach. The result is a significant divergence
in the treatment of patients, often even within the same unit, the impact of which
remains uncertain. There is an urgent need to evaluate the available evidence in a
measured and scientific fashion to prevent this gut feeling–based disparity of
treatment.
The Evidence
The ancient Romans aiming to please the people used to say, “Vox populi, vox dei!”
when deciding in the arena whether to put their thumbs up or (mostly) down. In the
same way, when auditing the efficacy of a new technique, the surgical scientific
community has shown lack of methodology and consistency, in most cases leaving
events to sort themselves out. This has been fortunate with the advent in coronary
surgery of the left internal thoracic artery graft1 but rather disappointing in other
cases, such as the advent of transmyocardial laser revascularization.2
With OPCAB, the surgical scientific community has tended to turn its thumb
down, continually demanding evidence. Actually, this has been fortunate, because
many off-pump centers have been prompted to design studies of good quality,
producing a number of prospective randomized trials, case-matched reports, and
observational reports. The best of them, as determined by study design, size of the
surgical population, and quality of the statistical analysis used, are discussed here.
Beating Heart Against Cardioplegic Arrest Study (BHACAS) 1 and 2 were two
single-center randomized trials carried out on a total population of 401 patients
undergoing elective operations (200 of which were performed off pump).3 Com-
pleteness of revascularization was similar between the two groups, and in-hospital
mortality did not differ (1% for on pump vs 0% for off pump). Benefits associated
with OPCAB included significant reductions in chest infection, inotropic require-
ment, incidence of arrhythmias, total chest tube drainage and consequent transfusion
requirement, intubation time, intensive care, hospital stay, and costs. The outcome
of a multicenter randomized trial in a cohort of 281 patients (142 undergoing
operations off pump) was reported by Van Dijk and coworkers4 and showed no
differences in terms of in-hospital mortality and morbidity. The patients undergoing
off-pump surgery, however, had a shorter ventilation time, were discharged 1 day
From the Bristol Heart Institute, University
of Bristol, Bristol, United Kingdom.
Received for publication June 30, 2002;
revisions requested July 1, 2002; revisions
received July 30, 2002; accepted for publi-
cation Aug 6, 2002.
Address for reprints: Gianni D. Angelini,
MD, Professor of Cardiac Surgery, Bristol
Heart Institute, Bristol Royal Infirmary,
Bristol BS2 8HW, United Kingdom (E-
mail: R.Ascione@bristol.ac.uk).
J Thorac Cardiovasc Surg 2003;125:779-81
Copyright © 2003 by The American Asso-
ciation for Thoracic Surgery
0022-5223/2003 $30.000
doi:10.1067/mtc.2003.11
Ascione and Angelini Editorials
The Journal of Thoracic and Cardiovascular Surgery ● Volume 125, Number 4 779
ED
IT
O
RI
A
L
earlier, and had a reduction of 41% in release of creatine
isoenzyme MB relative to the on-pump patients.
Although the results of prospective randomized studies
are rightly considered the criterion standard, they are not
powered to detect differences in more than few chosen end
points. Moreover, their findings cannot be uncritically ex-
tended to an entire surgical population if there are restricted
exclusionary criteria. For these reasons very large retrospec-
tive studies, supported by sophisticated statistical analysis
might be equally helpful. A recent study from Magee and
colleagues5 in a cohort of 8449 patients (1983 patients with
operations performed off pump) used propensity score anal-
ysis to demonstrate that elimination of cardiopulmonary
bypass improves early survival in patients undergoing mul-
tivessel coronary artery bypass grafting. Similarly, Cleve-
land and coworkers,6 in a multicenter retrospective risk-
adjusted analysis of 118,140 coronary artery bypass grafting
procedures without concomitant surgery drawn from the
National Adult Cardiac Surgery Database of The Society of
Thoracic Surgeons (11,717 of which were OPCAB),
showed significant benefits associated with OPCAB. These
included decreases in operative mortality (from 2.9% to
2.3%) and major complications such as deep sternal infec-
tion, bleeding, renal failure, and prolonged ventilation (from
14.1% to 10.6%). Similar results were reported by Calafiore
and associates.7 However, a major limitation of this kind of
study is the potential for bias related to differences in patient
selection, surgical technique, and, not least, surgical skill.
Comparisons assessing inflammatory and coagulation
activation and subsystem organ dysfunction also deserve
mention. Several studies have reported a significant attenu-
ation of inflammatory activation8,9 and coagulation impair-
ment3,5,7,10 with OPCAB relative to conventional surgery.
The lower release of troponin I during OPCAB4,11 suggests
limited myocardial injury, a possible explanation for the
reduced incidence of postoperative arrhythmias and inotro-
pic support among these patients.3,12 A protective effect of
OPCAB on renal function is suggested both by biochemical
evaluation in patients undergoing elective operations13 and
by the analysis of major clinical outcomes among patients at
higher risk for postoperative renal dysfunction either from
diabetes6 or from preoperative non–dialysis-dependent re-
nal insufficiency.14 A word of caution is needed regarding
the efficacy of OPCAB in preventing neuropsychologic
dysfunction. Although a lower release of S100 protein was
recorded soon after off-pump coronary surgery, the results
regarding early and late cognitive dysfunction are contro-
versial in the sense that they have been either better or
similar when compared with conventional surgery.15,16
There are many more studies in the literature on OPCAB,
and several on patients at higher risk who might benefit the
most from this procedure. The vast majority of these studies
report benefits associated with OPCAB, whereas the rem-
nant minority suggest that OPCAB is as good as conven-
tional surgery in terms of mortality and morbidity.17-19
One of the major criticisms of OPCAB is the perfor-
mance of suboptimal anastomoses, with the potential for
poor long-term results. The late clinical outcomes of the two
BHACAS trials (29.3  7.4 and 15.7  5.5 months for
BHACAS 1 and 2 respectively) showed no differences
between groups in terms of late mortality, cardiac-related
events, and need for further coronary revascularization pro-
cedure.3 These results are similar to those reported by van
Dijk and coworkers4 at 1 month of follow-up and are
supported by angiographic evidence reported by oth-
ers.7,20,21 Considering that conventional coronary surgery
has benefited from 30 years of surgical technical evolution,
the results of developed OPCAB are quite encouraging in
light of its relatively short life. Perhaps before the BHACAS
data OPCAB without stabilization devices and intracoro-
nary shunts suggested somewhat poorer long-term out-
come.22
The Implications of the Evidence
Since the renascence of OPCAB, its application has tended
to increase dramatically, although it still varies from 0% to
100% depending on the center. This may be a simple
reflection of the different phase of the learning curve at each
center; those that started their OPCAB programs several
years ago with small numbers of selected patients are now
performing this operation in 90% of their cases.6,7,18,21,23,24
Thousands of OPCAB procedures each year are already
being performed as consequence of the possibility of reduc-
ing morbidity, but this may also have a welcome economic
spin-off. The calculation of the in-hospital costs of the first
BHACAS trial showed a saving of about 25% per patient.22
However, the enthusiasm for OPCAB has not been uniform
within developed countries, as judged by the amount of
literature produced. The adoption of OPCAB in the United
Kingdom (for example) has rightly or wrongly been slower
than France, German, Italy, or the United States, and this
could be due to different approaches of these countries to a
recognized teaching program.
The evidence supporting OPCAB deserves for the scien-
tific community to call for a forum and make specific
recommendations. If it is agreed that the evidence is against
OPCAB, then those performing such procedures should
stop because they are affecting the quality of care of thou-
sands of patients worldwide. If, on the other hand, it is
agreed that the evidence for benefit of OPCAB is conclu-
sive, then the implications are of a different order. Imple-
mentation of OPCAB could improve the quality of care for
many patients operated on each year with conventional
techniques. This predicts the need for a recognized teaching
program that addresses genuine concerns about OPCAB,
the organization of dedicated audit systems of OPCAB, and,
not least, consideration of the ethical issue of those research
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projects designed to randomly assign patients to both tech-
niques purely for study purposes.
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